Pathogenesis and potential therapy of autosomal dominant polycystic kidney disease
Journal Title: Нирки - Year 2017, Vol 6, Issue 4
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disease characterized by progressive growth of the cyst and an increase in the total volume of the kidneys which leads to kidney failure. The main causes of ADPKD are mutations in the genes PKD1 and PKD2 which encode the formation of polycystin-1 and polycystin-2 proteins. There is a connection between structural and functional defects in the primary cilia with the ADPKD. The most promising drugs for the treatment of ADPKD today are vasopressin-2 receptor antagonists, m-TOR and c-AMP inhibitors.
Authors and Affiliations
O. O. Melnyk
Keywords
Related Articles
- EP ID EP234403
- DOI 10.22141/2307-1257.6.4.2017.114054
- Views 104
- Downloads 0
Antibiotic resistance and vaccination in patients with urinary tract infection
Limited in experience of using uroantiseptics, even those manufactured in European countries, such as Furamag and Macmiror, excessive use of antibiotics, which causes antibiotic resistance in the EU countries and form re...
Clinical case of successful treatment of Goodpasture syndrome with rituximab
.
Gitelman Syndrome: a Сlinical and Molecular Overview
Gitelman syndrome (OMIM #263800) is an autosomal recessive renal tubular disorder due to loss of function mutations of SLC12A3 gene, encoding the thiazide-inhibitable, electroneutral Na+-Cl– cotransporter (NCC) of the di...
Hypomagnesemia in Chronic Kidney Disease Stage 5
The article describes the clinical case of correction of hypomagnesemia in a patient 49 years with chronic kidney disease stage 5 with application magnesium orotate.
Antibiotic Resistance in Nephrological Practice
The problem of antibiotic resistance is a serious threat to the global public health and requires action by both the state and the public. The World Health Organization identified 15 most dangerous and prevalent superbug...